Glythera Appoints Chief Scientific Officer and Strengthens SAB

News   Jan 17, 2018 | Original story from Glythera

 
Glythera Appoints Chief Scientific Officer and Strengthens SAB

Dr Robert Lutz

 
 
 

RELATED ARTICLES

Researchers Discover Key Link Between Mitochondria and Cocaine Addiction

News

Researchers were able to block response in mitochondria to cocaine.

READ MORE

Insulin Goes Viral: Diabetes and Cancer-causing Mechanisms Explored

News

Every cell in your body responds to the hormone insulin, and if that process starts to fail, you get diabetes. In an unexpected finding, scientists have identified four viruses that can produce insulin-like hormones that are active on human cells. The discovery brings new possibilities for revealing biological mechanisms that may cause diabetes or cancer.

READ MORE

Pre-Clinical Safety in Cancer Drug Development: “Attitude to Safety Needs to Change”

News

Many companies involved in cancer drug research and development need to re-think their use of safety data in helping to bring new drugs to cancer patients.

Dr Richard Knight of ApconiX will tell this month’s conference, that greater focus on pre-clinical safety should be fundamental to the development of new cancer therapies.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE